Stock Taper
SCREENER COMPARE ANY 2 STOCKS
BIO-B
BIO-RAD LABORATORIES, INC.
NYSE
$387.06
▲ UP 6.02% (21.98)

KEY STATISTICS

Market Cap$10.59 B
52w High$387.10
52w Low$244.54
Dividend Yield—
Frequency—
P/E-68.15
Volume26
Shares Out.26.92M

COMPANY

LEADERSHIP

Norman D. Schwartz
CHIEF EXECUTIVE
Norman D. Schwartz

COMPENSATION 2026

Salary$1,089,877
Stock Awards$4,856,574
Incentive Plan Pay$562,088
All Other Comp.$28,327
Total$7,995,841

ABOUT

SECTOR
Healthcare
WENT PUBLIC
September 21, 1999
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
7,450

UPCOMING EARNINGS

DateOct 22, 2026
DayThursday
Rev. Est.$649.00M
OCT
22
THU

SPLIT RECORD

DATETYPERATIO
2002-03-08Forward2:1
1996-06-11Forward3:2
1986-06-13Forward3:2
1985-08-01Forward3:2
1980-03-19Forward2:1
1979-10-26Forward5:4
1978-11-09Forward5:4
1977-07-26Forward5:4
1976-08-26Forward5:4

PRICE

$387.06 ▲ UP 6.02% (+$21.98)
OVERLAYS
$387$387$3873:46 PM3:46 PM3:46 PM3:46 PM3:47 PM3:47 PM3:47 PM387.06

About Bio-Rad Laboratories, Inc.

https://www.bio-rad.com ↗

Bio-Rad Laboratories, Inc. develops and distributes life science research and clinical diagnostic products worldwide, serving research, biopharmaceutical, food safety, and clinical laboratories through its Life Science and Clinical Diagnostics seg...

INDUSTRY

Medical - Devices

A PRODUCT BIO-RAD LABORATORIES, INC. IS KNOWN FOR

Nuvia wPrime 2A Media
Nuvia wPrime 2A Media

A scalable mixed-mode chromatography resin combining weak anion exchange and hydrophobic interaction, designed for efficient biomolecule purification to meet the evolving needs of biotherapeutics and research markets.

COMPETITORS

COMPETITOR
A COMPARE
DHR COMPARE
RVTY COMPARE
TMO COMPARE
WAT COMPARE

Revenue by Products

IconPRODUCTQ3-2025Q4-2025Q1-2026Q2-2026
Clinical Diagnostics$391.2M $782.1M ▲$363.6M ▼$399M ▲
Life Science$261.8M $496.5M ▲$228.5M ▼$252M ▲

Revenue by Geography

MapREGIONQ3-2025Q4-2025Q1-2026Q2-2026
UNITED STATES$270M $485.8M ▲$229.8M ▼$255.5M ▲
Europe$222.2M $442.4M ▲$206.8M ▼$229.2M ▲
Asia Pacific$121M $265.9M ▲$110.4M ▼$121.8M ▲
Americas$39.8M $84.5M ▲$45.1M ▼$44.5M ▼

ETFS HOLDING THIS STOCK

ETFS HOLDING
2
LISTED HERE
1
RANKED BY POSITION SIZE
BSCW
0.27% · 4.1M

INSTITUTIONAL OWNERSHIP

SHARES OWNED
0.02%
HOLDERS
11
TOP 11 OF 11 · RANKED BY POSITION SIZE
Css LLC/Il
1.1K sh · $309.01K
Flow Traders U.S. LLC
985 sh · $274K
Buckingham Strategic Wealth, LLC
760 sh · $202.78K
Colony Group, LLC
760 sh · $211.47K
Morgan Stanley
712 sh · $198.11K
Ubs AG
514 sh · $58K
Wells Fargo & Company/Mn
170 sh · $47.3K
Whittier Trust Co
160 sh · $43.93K
Ubs Group AG
13 sh · $3.62K
Advisor Group, Inc.
1 sh · $0
Concourse Financial Group Securities, Inc.
0 sh · $0

RATINGS SNAPSHOT

Overall rating: B-

DCFROEROAD/EP/EP/B
Discounted Cash Flow3
Return On Equity3
Return On Assets1
Debt To Equity3
Price To Earnings1
Price To Book4
Overall Score3

INSIDER TRADES

★
OFFICER: EVP, PRESIDENT, CDG
ENGELHARDT EVA ANETTE
Purchase · 246 shares
2026-07-25
★
OFFICER: EVP, PRESIDENT, CDG
ENGELHARDT EVA ANETTE
Sale · 89 shares
2026-07-25
★
OFFICER: EVP, PRESIDENT, CDG
ENGELHARDT EVA ANETTE
Sale · 246 shares
2026-07-25
★
OFFICER: EVP, PRESIDENT, CDG
ENGELHARDT EVA ANETTE
Sale · 550 shares
2026-05-11

SECTORS PEERS

PEERPRICE
JAZZ$244.54COMPARE
PEN$321.68COMPARE
DVA$180.68COMPARE
GMED$82.97COMPARE
MOH$200.00COMPARE
HSIC$89.52COMPARE
CYTK$72.09COMPARE
HQY$96.37COMPARE